Literature DB >> 2611617

Is the treatment of urgency incontinence a placebo response? Results of a five-year follow-up.

M Aitchison1, R Carter, P Paterson, B Ferrie.   

Abstract

The treatment and symptomatic outcome were reviewed in 50 women who had presented with urgency incontinence as their main symptom 5 years previously. All had idiopathic urgency incontinence and, on the basis of urodynamic investigation, 40 were considered to have detrusor instability and 10 sensory urge incontinence. The results indicate that the natural history of sensory urgency is one of spontaneous resolution; all treatments of detrusor instability (including surgery) produced an unsustained short-term symptomatic response. This pattern of response to therapy may be interpreted as being largely of a placebo nature and this emphasises the need for long-term follow-up in the assessment of new treatment modalities.

Entities:  

Mesh:

Year:  1989        PMID: 2611617     DOI: 10.1111/j.1464-410x.1989.tb05280.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

1.  Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity?

Authors:  Bernard T Haylen; Naven Chetty; Vanessa Logan; Serena Schulz; Louise Verity; Matthew Law; Jialun Zhou
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-06

2.  Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.

Authors:  P Abrams; J Malone-Lee; B Jacquetin; J J Wyndaele; T Tammela; U Jonas; A Wein
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women.

Authors:  Peter K Sand; John Miklos; Henry Ritter; Rodney Appell
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004 Jul-Aug

4.  A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder.

Authors:  Soyon Lee; Bimal Malhotra; Dana Creanga; Martin Carlsson; Paul Glue
Journal:  BMC Med Res Methodol       Date:  2009-07-22       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.